Bereaved Parents clinical trials

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

View clinical trials related to Bereaved Parents.

Filter by:

None
Page 1

NCT ID: NCT00447174 Completed - Bereaved Parents Clinical Trials

Parental Bereavement Study Among Couples Coping Traumatic Loss of a Child

PBS

Start date: January 2007
Phase: N/A
Study type: Interventional

1. Develop a treatment for clinically significant parental bereavement. The proposed treatment development activities include: 1. Development of a treatment manual, associated fidelity rating forms, and training aids, 2. Pre-testing the treatment manual with bereaved parents, and revision in consultation with treatment development experts, 2. Conduct a randomized, wait-list control, pilot study of the proposed treatment: 1. Measure treatment-related change in (a) complicated grief symptoms, the primary outcome variable, which will be assessed using the Inventory of Complicated Grief, and, (b) marital adjustment, the secondary outcome measure, to be assessed using the Dyadic Adjustment Scale. These outcomes will be assessed in treatment and control groups at baseline, at treatment conclusion, and at three month follow-up. 2. Test the difference between the treatment and control groups on changes from baseline to three month follow-up on the exploratory outcome variables of PTSD, depression, social and work impairment, and quality of life 3. Estimate effect sizes of these differences in changes in outcomes 3. Develop a proposal for a randomized controlled trial of the treatment, based on the results of aim 2.